Best Peptides for Herniated Disc Support

Herniated disc support research focuses on peptides that may help modulate inflammatory responses and promote tissue repair in the intervertebral disc and surrounding structures. While no single peptide has emerged as the primary research target for this specific condition, peptides being studied for tissue repair and anti-inflammatory properties—such as BPC-157 and TB-500—are of interest to researchers exploring spinal disc degeneration. These peptides are being investigated for their potential to support fibroblast activity and reduce localized inflammation, though human clinical evidence specific to herniated discs remains limited.

Dosing protocols for herniated disc support peptides vary significantly depending on the specific peptide, route of administration (subcutaneous, intramuscular, or systemic), and individual research goals. Most research-based protocols operate in the range of 250-500 mcg per administration, with frequency varying from daily to several times weekly, though timing and duration should be determined based on individual response and specific research parameters.